1. WHO: World Malaria Report 2017. In World Malaria Report (World Health Organization ed.
http://www.who.int/malaria/publications/world-malaria-report-2017/en/
: World Health Organization; 2017.
2. Chiodini PLP, D. Whitty, C J.M. and Lalloo, D.G.: Guidelines for malaria prevention in travellers from the United Kingdom, 2017. England PH ed.
www.gov.uk/government/uploads/system/uploads/attachment_data/file/652892/Guidelines_for_malaria_prevention_in_travellers_from_the_UK_2017.pdf
: Public Health England; 2017.
3. WHO. Guidelines for the treatment of malaria. In: Guidelines for the treatment of malaria. 3rd edition. Geneva: World Health Organization; 2015. WHO Guidelines Approved by the Guidelines Review Committee.
4. Bousema JT, Gouagna LC, Meutstege AM, Okech BE, Akim NI, Githure JI, Beier JC, Sauerwein RW. Treatment failure of pyrimethamine-sulphadoxine and induction of Plasmodium falciparum gametocytaemia in children in western Kenya. Tropical Med Int Health. 2003;8:427–30.
5. Korsinczky M, Chen N, Kotecka B, Saul A, Rieckmann K, Cheng Q. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site. Antimicrob Agents Chemother. 2000;44:2100–8.